Literature DB >> 8971819

Management of 1000 vestibular schwannomas (acoustic neuromas): surgical management and results with an emphasis on complications and how to avoid them.

M Samii1, C Matthies.   

Abstract

OBJECTIVE: To identify the actual benefits and persisting problems in treating vestibular schwannomas by the suboccipital approach, the results and complications in a consecutive series of 1000 tumors surgically treated by the senior author were analyzed and compared with experiences involving other treatment modalities.
METHODS: Pre- and postoperative clinical statuses were determined and radiological and surgical findings were collected and evaluated in a large database for 962 patients undergoing 1000 vestibular schwannoma operations at Nordstadt's neurosurgical department from 1978 to 1993.
RESULTS: By the suboccipital transmeatal approach, 979 tumors were completely removed; in 21 cases, deliberate partial removal was performed either in severely ill patients for decompression of the brain stem or in an attempt to preserve hearing in the last hearing ear. Anatomic preservation of the facial nerve was achieved in 93% of the patients and of the cochlear nerve in 68%. Major neurological complications included 1 case of tetraparesis, 10 cases of hemiparesis, and caudal cranial nerve palsies in 5.5% of the cases. Surgical complications included hematomas in 2.2% of the cases, cerebrospinal fluid fistulas in 9.2%, hydrocephalus in 2.3%, bacterial meningitis in 1.2%, and wound revisions in 1.1%. There were 11 deaths occurring at 2 to 69 days postoperatively (1.1%). The techniques that were developed for avoidance of complications are reported. The analysis identifies preexisting severe general and/or neurological morbidity, cystic tumor formation, and major caudal cranial nerve deficits as relevant risk factors.
CONCLUSION: The current treatment options of complete tumor resection with ongoing reduction of morbidity are well fulfilled by the suboccipital approach. By careful patient selection, the mortality rate should be further reduced to below 1%.

Entities:  

Mesh:

Year:  1997        PMID: 8971819     DOI: 10.1097/00006123-199701000-00002

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  85 in total

1.  Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2.

Authors:  Jaishri O Blakeley; D Gareth Evans; John Adler; Derald Brackmann; Ruihong Chen; Rosalie E Ferner; C Oliver Hanemann; Gordon Harris; Susan M Huson; Abraham Jacob; Michel Kalamarides; Matthias A Karajannis; Bruce R Korf; Victor-Felix Mautner; Andrea I McClatchey; Harry Miao; Scott R Plotkin; William Slattery; Anat O Stemmer-Rachamimov; D Bradley Welling; Patrick Y Wen; Brigitte Widemann; Kim Hunter-Schaedle; Marco Giovannini
Journal:  Am J Med Genet A       Date:  2011-12-02       Impact factor: 2.802

2.  [Function of the facial nerve after operative treatment of acoustic neurinomas. Influence of intraoperative monitoring].

Authors:  A Nabhan; F Ahlhelm; W Reith; W-I Steudel; K Schwerdtfeger
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

3.  Therapeutic strategy for large vestibular schwannomas.

Authors:  Chul-Kee Park; Hee-Won Jung; Jeong Eun Kim; Young-Je Son; Sun Ha Paek; Dong Gyu Kim
Journal:  J Neurooncol       Date:  2006-04       Impact factor: 4.130

4.  The enlarged translabyrinthine and transapical extension type I approach for large vestibular schwannomas.

Authors:  N Jayashankar; K P Morwani; S K Sankhla; R Agrawal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-01-01

5.  The Changing Paradigm for the Surgical Treatment of Large Vestibular Schwannomas.

Authors:  Roy Thomas Daniel; Constantin Tuleasca; Alda Rocca; Mercy George; Etienne Pralong; Luis Schiappacasse; Michele Zeverino; Raphael Maire; Mahmoud Messerer; Marc Levivier
Journal:  J Neurol Surg B Skull Base       Date:  2018-08-23

6.  Treatment of large and giant residual and recurrent vestibular schwannomas.

Authors:  Ricardo Ramina; Maurício Coelho Neto; Kelly Cristina Bordignon; Tobias Mattei; Rogério Clemente; Paulo Henrique Pires Aguiar
Journal:  Skull Base       Date:  2007-03

7.  Evaluation of variation in the course of the facial nerve, nerve adhesion to tumors, and postoperative facial palsy in acoustic neuroma.

Authors:  Tetsuro Sameshima; Akio Morita; Rokuya Tanikawa; Takanori Fukushima; Allan H Friedman; Francesco Zenga; Alessandro Ducati; Luciano Mastronardi
Journal:  J Neurol Surg B Skull Base       Date:  2012-11-26

8.  Radiological and Clinical Factors Predicting the Facial Nerve Outcome following Retrosigmoid Approach for Large Vestibular Schwannomas (VSs).

Authors:  Mayur Sharma; Ashish Sonig; Sudheer Ambekar; Anil Nanda
Journal:  J Neurol Surg B Skull Base       Date:  2013-06-25

9.  "Large and giant vestibular schwannomas: overall outcomes and the factors influencing facial nerve function".

Authors:  Golda Grinblat; Manjunath Dandinarasaiah; Itzak Braverman; Abdelkader Taibah; Dario Giuseppe Lisma; Mario Sanna
Journal:  Neurosurg Rev       Date:  2020-08-29       Impact factor: 3.042

10.  Revision Surgery for Vestibular Schwannomas.

Authors:  Kevin A Peng; Brian S Chen; Mark B Lorenz; Gregory P Lekovic; Marc S Schwartz; William H Slattery; Eric P Wilkinson
Journal:  J Neurol Surg B Skull Base       Date:  2018-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.